Skip to main content
Fig. 3 | BMC Cancer

Fig. 3

From: Improving gastric cancer preclinical studies using diverse in vitro and in vivo model systems

Fig. 3

Assessment of concordance of in vivo ERBB2 proteins levels in five distinct gastric cancer cell lines, as determined by H&E (hematoxylin and eosin stain, left panel) and immunohistochemistry (IHC, middle panel) and ERBB2 gene expression levels, as determined by silver in situ hybridization (SISH, right panel), using five separate cell (CMAs) a or xenograft b microarrays (XMAs)

Back to article page